No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver disease

Alcoholism: Clinical and Experimental Research

Volumn 32, Issue 6, 2008, Pages 959-965

  Stickel, Felix ^a   Österreicher, Christoph H ^b   Halangk, Juliane ^c   Berg, Thomas ^c   Homann, Nils ^d   Hellerbrand, Claus ^e   Patsenker, Eleonora ^a   Schneider, Vreni ^a   Kolb, Armin ^f   Friess, Helmut ^f   Schuppan, Detlef ^g   Puhl, Gero ^c   Seitz, Helmut K ^h   Leathart, Julian L B ⁱ   Day, Christopher P ⁱ  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^h Krankenhaus Salem   (Germany)

ⁱ NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Alcoholic Liver Disease; Cirrhosis; Genetic Risk; Matrixmetalloproteinase 3 Polymorphism

Indexed keywords

MESSENGER RNA; STROMELYSIN;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CORRELATION ANALYSIS; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; GERMANY; HARDY WEINBERG DISTRIBUTION LAW; HUMAN; HUMAN TISSUE; LIVER; LIVER DISEASE; LIVER INJURY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE STRAND CONFIRMATION POLYMORPHISM; UNITED KINGDOM;

ADULT; ANALYSIS OF VARIANCE; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; GREAT BRITAIN; HUMANS; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; LOGISTIC MODELS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 44349132734     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2008.00654.x     Document Type: Article

References (24)

1. Bataller R, North KE, Brenner DA (2003) Genetic polymorphisms and the progression of liver fibrosis: a critical apraisal. Hepatology 37 : 493 503.
2. Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Muller CF, Schnohr P, Jensen G (1996) Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 23 : 1025 1029.
3. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria CroceL, Sasso F, Pozzato G, Cristianini G, Brando G, the Dionysos Study Group (1997) Drinking habits as cofactors of risk for alcohol induced liver damage. Gut 41 : 845 850.
4. Benyon RC, Arthur MJ (2001) Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 21 : 373 384.
5. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC (2001) Analysis of the VNTR locus DIS80 by the PCR followed by high resolution PAGE. Am J Hum Genet 48 : 137 144.
6. Cardon LR, Bell JI (2001) Association study designs for complex diseases. Nat Rev 2 : 91 99.
7. Gnasso A, Motti C, Irace C, Carallo C, Liberatoscioli L, Bernardini S, Massoud R, Mattioli PL, Federici G, Cortese C (2000) Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. Arterioscler Thromb Vasc Biol 20 : 1600 1605.
8. Harris DR, Gonin R, Alter HJ, Wright EC, Buskell ZJ, Hollinger FB, Seeff LB, National Heart, Lung, and Blood Institute Study Group (2001) The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med 134 : 120 124.
9. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG (2001) Replication validity of genetic association studies. Nat Genet 29 : 306 309.
10. Lichtinghagen R, Bahr MJ, Wehmeier M, Michels D, Haberkorn CI, Arndt B, Flemming P, Manns MP, Boeker KH (2003) Expression and coordinate regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis. Clin Sci 105 : 373 382.
11. Liechti-Gallati S, Schneider V, Neeser D, Kraemer R (1999) Two buffer PAGE system-based SSCP/HD analysis: a general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic disease. Eur J Hum Genet 7 : 590 598.
12. Okamoto K, Mimura K, Murawaki Y, Yuasa I (2005) Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. J Gastroenterol Hepatol 20 : 1102 1108.
13. Osterreicher CH, Stickel F, Brenner DA (2007) Genomics of liver fibrosis and cirrhosis. Semin Liver Dis 27 : 28 43.
14. Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, Naveau S (2002) Risk factors of fibrosis in alcoholic liver disease. Hepatology 35 : 635 638.
15. Reed T, Page WF, Viken RJ, Christian JC (1996) Genetic disposition to organ-specific endpoints of alcoholism. Alcohol Clin Exp Res 20 : 1528 1533.
16. Satsangi J, Chapman RWG, Haldar N, Donaldson P, Mitchell S, Simmons J, Norris S, Marshall SE, Bell JI, Jewell DP, Welsh KI (2001) A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology 121 : 124 130.
17. Schulze-Krebs A, Preimel D, Popov Y, Bartenschlager R, Lohmann V, Pinzani M, Schuppan D (2005) Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. Gastroenterology 129 : 246 258.
18. Schuppan D, Rühl M, Somasundaram R, Hahn EG (2001) Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 21 : 351 372.
19. Stickel F, Österreicher CH (2006) Genetic factors in alcoholic liver disease. Alcohol Alcohol 41 : 209 224.
20. Teli MR, Day CP, Burt AD, Bennett MK, James OF (1995) Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346 : 987 990.
21. Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM (2004) Association of matrixmetalloproteinase-1 and -3 promoter polymorphism with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol 41 : 209 214.
22. Wilfred de Alwis NM, Day CP (2007) Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin Liver Dis 27 : 44 54.
23. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 271 : 13055 13060.
24. Zintzaras E, Stafanidis I, Santos M, Vidal F (2006) Do alcohol-metabolizing enzyme polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology 43 : 352 361.